Human Bone Morphogenetic Protein-2 Use for Maxillary Reconstruction in Cleft Lip and Palate Patients
Authors:
- Lady Wilson CananLCLady Wilson Canan
- Renato da Silva FreitasRFRenato da Silva Freitas
- Nivaldo AlonsoNANivaldo Alonso
- Daniela Yukie Sakai TanikawaDTDaniela Yukie Sakai Tanikawa
- Diógenes Laércio RochaDRDiógenes Laércio Rocha
- Julio Cezar Uili CoelhoJCJulio Cezar Uili Coelho
- 1 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 23 (6) , 1627-1633
Abstract
The conventional methods of maxillary alveolar reconstruction in patient with cleft are the periosteoplasty and autologous bone grafting. As an important alternative of bone substitution, there is the recombinant human bone morphogenetic protein-2 (rhBMP-2). This study compares the rhBMP-2 with periosteoplasty and autologous bone grafting. Patients with cleft and alveolar defect were divided into 3 groups of 6 patients who underwent to autologous iliac crest bone grafting, resorbable collagen sponge with rhBMP2, and periosteoplasty, respectively. The analysis was performed through computed tomographic scan preoperatively and at months 3, 6, and 12 postoperatively. The variables analyzed were the alveolar defect volume, formed bone volume, bone formation rate, maxillary height repair rate, and the formed bone density mean. The formed bone volume was similar comparing the bone graft and BMP groups at 1-year postoperative analysis (P = 0.58). Both of them had the formed bone volume significantly larger than the periosteoplasty group at 3 and 6 months postoperatively. In this last group, the 1-year follow-up was canceled because the bone formation was insufficient. The bone formation rate, the maxillary height repair rate, and the mean of density of the formed bone were similar in the bone graft and BMP groups at 1-year follow-up with P values of 0.93, 0.90, and 0.81, respectively. The amount of formed bone in the periosteoplasty group was insufficient. There was no difference among the bone graft and rhBMP-2 therapy considering the parameters analyzed.Keywords
This publication has 16 references indexed in Scilit:
- Biomaterials in craniofacial reconstructionClinics in Plastic Surgery, 2004
- CLINICAL APPLICATIONS OF RECOMBINANT HUMAN BMPSJournal of Bone and Joint Surgery, 2003
- Bone growth factors in maxillofacial skeletal reconstructionInternational Journal of Oral and Maxillofacial Surgery, 2002
- Human recombinant BMP-2 in osseous reconstruction of simulated cleft palate defectsBritish Journal of Oral and Maxillofacial Surgery, 1998
- Retrospective analysis of 135 secondary alveolar cleft grafts using iliac or calvarial boneJournal of Oral and Maxillofacial Surgery, 1991
- Long-term results after secondary bone grafting of alveolar cleftsJournal of Oral and Maxillofacial Surgery, 1987
- Secondary Bone Grafting of Alveolar Clefts: A Surgical/Orthodontic Treatment Enabling a Non-prosthodontic Rehabilitation in Cleft Lip and Palate PatientsScandinavian Journal of Plastic and Reconstructive Surgery, 1981
- The Influence of Primary Periosteoplasty on Maxillary Growth and Deciduous Occlusion in Cases of Complete Unilateral Cleft Lip and Palate: A Longitudinal Study from Infancy to the Age of 5Scandinavian Journal of Plastic and Reconstructive Surgery, 1976
- Use of Marrow-Cancellous Bone Grafts in Maxillary Alveolar and Palatal CleftsJournal of Dental Research, 1974
- Bone: Formation by AutoinductionScience, 1965